Fibromyalgia and related syndromes

Rheumatology: Sixth Edition

Volumn 1-2, Issue , 2015, Pages 659-670

  Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944040824     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-09138-1.00080-2     Document Type: Chapter

References (84)

1. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-952.
2. Smythe HA, Moldofsky H Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977, 28:928-931.
3. Moldofsky H, Scarisbrick P, England R, Smythe H Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975, 37:341-351.
4. Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981, 11:151-171.
5. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
6. Yunus MB Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992, 19:846-850.
7. Clauw DJ, Chrousos GP Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997, 4:134-153.
8. McBeth J, Jones K Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2007, 21:403-425.
9. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011, 38:1113-1122.
10. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
11. Williams DA, Clauw DJ Understanding fibromyalgia: lessons from the broader pain research community. J Pain 2009, 10:777-791.
12. Phillips K, Clauw DJ Central pain mechanisms in chronic pain states-maybe it is all in their head. Best Pract Res Clin Rheumatol 2011, 25:141-154.
13. Wolfe F The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997, 56:268-271.
14. Petzke F, Ambrose K, Gracely RH, Clauw DJ What do tender points measure?. Arthritis Rheum 1999, 42:S342.
15. Croft P, Burt J, Schollum J, et al. More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?. Ann Rheum Dis 1996, 55:482-485.
16. Mork PJ, Nilsen TI Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum 2012, 64:281-284.
17. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W Genetic architecture of human pain perception. Trends Genet 2007, 23:605-613.
18. Buskila D, Neumann L, Hazanov I, Carmi R Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996, 26:605-611.
19. Markkula R, Jarvinen P, Leino-Arjas P, et al. Clustering of symptoms associated with fibromyalgia in a Finnish Twin Cohort. Eur J Pain 2009, 13:744-750.
20. Kato K, Sullivan PF, Evengard B, Pedersen NL A population-based twin study of functional somatic syndromes. Psychol Med 2009, 39:497-505.
21. Smith SB, Maixner DW, Fillingim RB, et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2012, 64:584-593.
22. Buskila D, Sarzi-Puttini P, Ablin JN The genetics of fibromyalgia syndrome. Pharmacogenomics 2007, 8:67-74.
23. Buskila D, Atzeni F, Sarzi-Puttini P Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev 2008, 8:41-43.
24. McLean SA, Clauw DJ Predicting chronic symptoms after an acute "stressor"-lessons learned from 3 medical conditions. Med Hypotheses 2004, 63:653-658.
25. Lee YC, Nassikas NJ, Clauw DJ The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther 2011, 13:211.
26. Raphael KG, Natelson BH, Janal MN, Nayak S A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain 2002, 100:131-139.
27. Williams DA, Brown SC, Clauw DJ, Gendreau RM Self-reported symptoms before and after September 11 in patients with fibromyalgia. JAMA 2003, 289:1637-1638.
28. Glass JM, Lyden A, Petzke F, Clauw D The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 2004, 57:391-398.
29. McBeth J, Morris S, Benjamin S, Silman AJ, Macfarlane GJ Associations between adverse events in childhood and chronic widespread pain in adulthood: are they explained by differential recall?. J Rheumatol 2001, 28:2305-2309.
30. Arguelles LM, Afari N, Buchwald DS, et al. A twin study of posttraumatic stress disorder symptoms and chronic widespread pain. Pain 2006, 124:150-157.
31. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994, 37:1583-1592.
32. Martinez-Lavin M, Hermosillo AG, Rosas M, Soto ME Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 1998, 41:1966-1971.
33. McLean SA, Williams DA, Stein PK, et al. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 2006, 31:2776-2782.
34. Light AR, White AT, Hughen RW, Light KC Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain 2009, 10:1099-1112.
35. Tchivileva IE, Lim PF, Smith SB, et al. Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics 2010, 20:239-248.
36. Pae CU, Luyten P, Marks DM, et al. The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin 2008, 24:2359-2371.
37. Gracely RH A pain psychologist's view of tenderness in fibromyalgia. J Rheumatol 2007, 34:912-913.
38. Gerster JC, Hadj-Djilani A Hearing and vestibular abnormalities in primary fibrositis syndrome. J Rheumatol 1984, 11:678-680.
39. Geisser ME, Glass JM, Rajcevska LD, et al. A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 2008, 9:417-422.
40. Craig AD Human feelings: why are some more aware than others?. Trends Cogn Sci 2004, 8:239-241.
41. Julien N, Goffaux P, Arsenault P, Marchand S Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005, 114:295-302.
42. Baraniuk JN, Whalen G, Cunningham J, Clauw DJ Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 2004, 5:48.
43. Chalaye P, Goffaux P, Bourgault P, et al. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 2012, 28:519-526.
44. Younger J, Mackey S Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 2009, 10:663-672.
45. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012, 153:1193-1198.
46. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165-175.
47. Potvin S, Paul-Savoie E, Morin M, Bourgault P, Marchand S Temporal summation of pain is not amplified in a large proportion of fibromyalgia patients. Pain Res Treat 2012, 2012:938595.
48. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593-1601.
49. Sarchielli P, Di Filippo M, Nardi K, Calabresi P Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 2007, 11:343-351.
50. Harris RE, Sundgren PC, Craig AD, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009, 60:3146-3152.
51. Harris RE, Napadow V, Huggins JP, et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 2013.
52. Gracely RH, Petzke F, Wolf JM, Clauw DJ Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343.
53. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005, 52:1577-1584.
54. Napadow V, Kim J, Clauw DJ, Harris RE Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum 2012, 64:2398-2403.
55. Jensen KB, Loitoile R, Kosek E, et al. Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain 2012, 8:32.
56. Wood PB, Schweinhardt P, Jaeger E, et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 2007, 25:3576-3582.
57. Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007, 27:10000-10006.
58. Foerster BR, Petrou M, Edden RA, et al. Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum 2012, 64:579-583.
59. Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 2012, 242:33-38.
60. Caro XJ, Winter EF, Dumas AJ A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford) 2008, 47:208-211.
61. Oaklander AL, Fields HL Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy?. Ann Neurol 2009, 65:629-638.
62. Hsu MC, Harris RE, Sundgren PC, et al. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain 2009, 143:262-267.
63. Affaitati G, Costantini R, Fabrizio A, et al. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 2011, 15:61-69.
64. Lentz MJ, Landis CA, Rothermel J, Shaver JL Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999, 26:1586-1592.
65. Chervin RD, Teodorescu M, Kushwaha R, et al. Objective measures of disordered sleep in fibromyalgia. J Rheumatol 2009, 36:2009-2016.
66. Boissevain MD, McCain GA Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain 1991, 45:239-248.
67. Hawley DJ, Wolfe F Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 1991, 18:1552-1557.
68. Hsu MC, Schubiner H, Lumley MA, et al. Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial. J Gen Intern Med 2010, 25:1064-1070.
69. Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009, 73:52-57.
70. Geisser ME, Strader DC, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics 2008, 49:235-242.
71. Chandran AB, Coon CD, Martin SA, et al. Sphygmomanometry-evoked allodynia in chronic pain patients with and without fibromyalgia. Nurs Res 2012, 61:363-368.
72. Goldenberg DL, Burckhardt C, Crofford L Management of fibromyalgia syndrome. JAMA 2004, 292:2388-2395.
73. Annemans L, Wessely S, Spaepen E, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 2008, 58:895-902.
74. Arnold LM, Keck PE, Welge JA Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000, 41:104-113.
75. Moldofsky H, Harris HW, Archambault WT, Kwong T, Lederman S Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J Rheumatol 2011, 38:2653-2663.
76. Arnold LM Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 2007, (8 Suppl 2):S63-S74.
77. Fishbain D Evidence-based data on pain relief with antidepressants. Ann Med 2000, 32:305-316.
78. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008, 30:1988-2004.
79. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004, 50:2974-2984.
80. Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2012, 64:2387-2397.
81. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005, 52:1264-1273.
82. Russell IJ, Holman AJ, Swick TJ, et al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011, 152:1007-1017.
83. Lynch ME, Campbell F Cannabinoids for the treatment of non-cancer pain: a systematic review of randomized trials. Br J Pharmacology 2011, 72:735-741.
84. Williams DA, Cary MA, Glazer LJ, Rodriguez AM, Clauw DJ Randomized controlled trial of CBT to improve functional status in fibromyalgia. Arthritis Rheum 2000, 43:S210.